Pulling SEC filings + quote and writing the call…
RCKT
ROCKET PHARMACEUTICALS, INC.
Next earnings Aug 5, 2026 (after close) · consensus $0.19 EPS
Last earnings -4.9% on 2026-05-07
$3.46
▲ +3.28%$3.46▲ +20.14%
over 1Y
L $2.45EODHDH $5.30
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+3.3%
1W+21.0%
1M+15.3%
3M-20.3%
YTD+0.0%
1Y+20.1%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 20 analysts
Buy
Conservative balance sheet (liabilities/equity 0.19x).
ROCKET PHARMACEUTICALS, INC. shows $0.00 in FY2025 revenue, and -80.5% ROE.
Sources: SEC EDGAR (CIK 0001281895, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 10:25:34 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.